跳至主要内容
临床试验/IRCT20211102052941N1
IRCT20211102052941N1已完成3 期

Comparative study of the effect of milrinone and dobutamine on pulmonary hypertension after adult heart valve replacement surgery

Esfahan University of Medical Sciences0 个研究点目标入组 38 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
38

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Patients who are candidate for heart valve transplantation and suffering pulmonary hypertension (right ventricular systolic pressure =50mmHg or meanPAP =40 mmHg or systolic PAP is mor than 50% of systemic systolic pressure)
  • The age over 18 years old
  • The consent of patient to being involved

排除标准

  • Renal and hepatic failure
  • Emergent surgery
  • Necessity to inotropic drugs before surgery
  • Long QT interval patients
  • Drug allergy

研究者

相似试验

Comparison of the effect of milrinone and dobutamine... | 临床试验